The other side of the sword
From Hijiya et al., JAMA 2007: Chemotherapy for acute lymphoblastic leukemia is good. Very good. But it’s a two-edged sword. One side creates long-term cancer survivors. The other creates secondary malignancies in cancer survivors.
